Recombinant human tumor necrosis factor (TNF) binding protein-1 (r-hTB
P-1) and recombinant human soluble dimeric TNF receptor (rhu TNFR:Fc)
were used to determine the relative contributions of TNF to phorbol my
ristate acetate (PMA) and cytokine-induced human immunodeficiency viru
s type I (HIV-1) replication in chronically infected cell lines. Treat
ment of HIV-1-infected promonocytic U1 cells with r-hTBP-1 or rhu TNFR
:Fc reduced PMA-induced HIV-1 p24 antigen production in a concentratio
n-dependent manner, with a maximal inhibition of approximately 90%. Ma
ximal inhibition of p24 antigen production in T-lymphocytic ACH-2 cell
s was 47% with r-hTBP-1 and 42% with rhu TNFR:Fc. r-hTBP-1 and rhu TNF
R:Fc also decreased p24 antigen synthesized by U1 cells in response to
other stimuli, including phytohemagglutinin (PHA)-induced supernatant
, granulocyte-macrophage colony-stimulating factor, interleukin-h, and
TNF. Addition of r-hTBP-1 to UI cells during the last 4 h of a 24 h i
ncubation with PMA still inhibited p24 antigen production by 15%. U1 c
ells stimulated with 10(-7) M PMA released similar to 1 ng/ml endogeno
us TBP-1 with an initial peak observed at I h and a second peak at 24
h after PMA stimulation. r-hTBP-1 also partially reversed inhibition o
f U1 cellular proliferation caused by PMA. Both r-hTBP-1 and rhu TNFR:
Fc blocked PMA induction of nuclear factor (NK)-kappa B DNA-binding ac
tivity in U1 cells in association with decreases in HIV-1 replication.
We conclude that soluble TNF receptors can inhibit stimuli-induced HI
V-1 expression and NF-kappa B DNA-binding activity in chronically infe
cted U1 cells.